Related Experiment Videos
Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosis
Insights
Repeat percutaneous transluminal coronary angioplasty (PTCA) for restenosis is highly successful with a low complication rate. Most patients experience long-term relief from angina and avoid further procedures or myocardial infarction (MI).
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Coronary restenosis after percutaneous transluminal coronary angioplasty (PTCA) is a significant clinical challenge.
- Repeat interventions are often necessary to manage restenosis, but their outcomes require careful evaluation.
Purpose of the Study:
- To analyze the short- and long-term outcomes of patients undergoing repeat PTCA for coronary restenosis.
- To assess the success rate, complication profile, and long-term efficacy of repeat PTCA.
Main Methods:
- Analysis of patient data from the NHLBI PTCA Registry.
- Inclusion of patients who underwent a successful initial PTCA and subsequently developed restenosis requiring repeat PTCA.
- Follow-up included clinical events (MI, CABG, mortality) and angiographic assessment.
Main Results:
- Repeat PTCA was successful in 85.2% of cases.
- Complications were low: 1.5% myocardial infarction (MI), 2% emergency coronary artery bypass grafting (CABG). No procedural deaths.
- Long-term follow-up (1-3 years) showed 75.9% of patients remained free from subsequent PTCA, CABG, or MI, with a late mortality rate of 0.8%.
Conclusions:
- Repeat PTCA for coronary restenosis demonstrates a high success rate and a low complication profile.
- The procedure offers sustained benefits, with most patients remaining free of angina and avoiding further major interventions.
- Repeat PTCA should be considered a valuable and integral part of managing coronary restenosis.
Abstract:
The short- and long-term outcome of patients within the NHLBI PTCA Registry who underwent repeat PTCA for coronary restenosis were analyzed. Of 1,880 patients in whom an initial PTCA was successful, 203 had a repeat PTCA attempted after restenosis developed. Repeat PTCA was usually performed within 6 months of the first procedure. The success rate of repeat PTCA was 85.2%. As a direct result of repeat PTCA, 1.5% of patients had an MI and 2% required emergency CABG. No patient died as a result of the attempted second procedure. One to 3 years of follow-up information was available in 94% of eligible patients. Most patients (75.9%) did not have a subsequent (third) PTCA, CABG or an MI. The late mortality rate was 0.8%. Angiographic follow-up information was available in 62 patients. Sustained enhancement of the diameter of the redilated lesion was observed in 66%. Thus, repeat PTCA has a high success and a low complication rate. Most patients did not have subsequent restenosis and are free of angina. Hence, repeat PTCA should be recommended for patients who have restenosis and should be considered as an integral component of PTCA therapy.